$100+ billion deals?, page-17

I think a few people noticed the purchase by SL and RT.

I mean SL is an expert in Hepatits B.
A deal here would be in the vicintity of US 200-300+ alone.

RT....well he has deep pockets. He actually bought some more on market!

BIT is way undervalued....before the new coronavirus came along.


What people fail to realize is BIt is different mode of action from a lot of the new stuff.
It can be rapidly deployed.
They have a platform and a big library of compounds ... which have broad antiviral capabilities.Drugs capable of targeting viruses
in reservoir cells.

100 billion is higher end of the scale and probably too early ....but possible.
10 billion is very conservative.

If they can develop a new compound for the New CoronaVirus, within 1 month, it shows the true value of their platform.
Such Rapid development of compounds to target such pandemics is highly attractive.

National Security against Biothreats is becoming a priority for governments and others.

China could easily do a deal within a month with Biotron for US$500 million.
They could easily fastrack approval for New CoronaVirus.

A city of 10 million people in lockdown.

Biotron already have CoronaVirus expertise.

So what is the value of BIT225 and other compounds?
Hep C, Hep B, EBV, Zika, SARS, Flu, Dengue compounds?
They have over 400!

Whilst $100 billions seems high at this stage....$10 Billion is still looking conservative IMHO.

Note. BIT225 has undergone 12 years of testing. Extremely high safety profile.
And it restores immune response.

There will be a revaluation of BIT if the anti NewCoronaVirus compounds works.
Remember they have the virus isolated and in labs already. This is unprecedented.